The Lung Cancer Therapeutics Market is predicted to reach US$ by 2030 from US$ 9.9 billion in 2021, and to grow at a CAGR of 10.70% between the forecast period 2022 to 2030.

The research report includes specific segments by Products/Type and by Application, by region (country). This study provides information about the sales and revenue of each segment during the historic and forecasted period from 2022 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

This report also provides information on the prevalent market dynamics such as market drivers and restraints and future growth opportunities anticipated within the forecast period. The report includes competitive landscape of the top players operating in the market for the base year 2021. The company profiles section of the report studies the position of the major market players based on considerations such as business profile, product/service portfolio, trailing annual revenues, and recent strategies.

Major segmentation covered in this report is as follows:

By Disease Type (Small cell Lung Cancer (SCLC), Non-small Cell lung Cancer (NSCLC)), By Treatment Type (Chemotherapy, Immunotherapy, Targeted Therapy)

By Region

North America, Europe, Asia Pacific, and the Rest of the World

Major market players covered in this study are

Bristol-Myers Squibb Company, F. Hoffman-La Roche Ltd., Pfizer Inc., Eli Lilly and Company, Johnson & Johnson Services, Inc., Amgen Inc., AstraZeneca plc., Teva Pharmaceutical Industries Ltd., Abbvie Inc., Novartis AG, Merck & Co., Inc. and GSK plc among others

1. INTRODUCTION
1. Market Ecosystem
2. Timeline Under Consideration
1. Historical Years - 2020
2. Base Year - 2021
3. Forecasted Years - 2022 to 2030
3. Currency Used in the Report
2. RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
1. Secondary Sources
2. Primary Sources
4. Market Estimation Approach
1. Bottom Up
2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
3. PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021)
4. MARKET DYNAMICS
1. Drivers
2. Restraints
3. Opportunities
5. GLOBAL Lung Cancer Therapeutics - ANALYSIS & FORECAST, BY PRODUCT
Product 1, Product 2
6. GLOBAL Lung Cancer Therapeutics - ANALYSIS & FORECAST, BY TYPE
Type 1, Type 2
1. GLOBAL Lung Cancer Therapeutics - ANALYSIS & FORECAST, BY END USER
End User 1, End User 2
2. GLOBAL Lung Cancer Therapeutics - ANALYSIS & FORECAST, BY REGION
North America Lung Cancer Therapeutics
1. North America Lung Cancer Therapeutics , by Country
1. US
2. Canada
1. North America Lung Cancer Therapeutics , by Product
2. North America Lung Cancer Therapeutics , by Type
3. North America Lung Cancer Therapeutics , by Gender
4. North America Lung Cancer Therapeutics , by Sales Channel
3. Europe Lung Cancer Therapeutics
1. Europe Lung Cancer Therapeutics , by Country/Region
1. Germany
2. UK
3. France
4. Rest of Europe
2. Europe Lung Cancer Therapeutics , by Product
3. Europe Lung Cancer Therapeutics , by Type
4. Europe Lung Cancer Therapeutics , by Gender
5. Europe Lung Cancer Therapeutics , by Sales Channel
4. Asia Pacific Lung Cancer Therapeutics
1. Asia Pacific Lung Cancer Therapeutics , by Country/Region
1. China
2. Japan
3. India
4. Rest of Asia Pacific
2. Asia Pacific Lung Cancer Therapeutics , by product
3. Asia Pacific Lung Cancer Therapeutics , by Type
4. Asia Pacific Lung Cancer Therapeutics , by Gender
5. Asia Pacific Lung Cancer Therapeutics , by Sales Channel
5. Rest of the World Lung Cancer Therapeutics
1. Rest of the World Lung Cancer Therapeutics , by Region
1. Latin America
2. Middle East & Africa
2. Rest of the World Lung Cancer Therapeutics , by Product
3. Rest of the World Lung Cancer Therapeutics , by Type
4. Rest of the World Lung Cancer Therapeutics , by Gender
5. Rest of the World Lung Cancer Therapeutics , by Sales Channel
2. COMPANY PROFILES
Company 1, Company 54

Asia Pacific Nuclear Medicine Market Size, Share, Trends & Analysis by Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters)), by Application (Neurology, Cardiology, Oncology, Others), by End User (Hospitals & Clinics, Diagnostic Centers, Others) and Region, with Forecasts from 2024 to 2034....

Market Overview The Asia Pacific Nuclear Medicine Market is poised for significant growth from 2024 to 2034, driven by advancements in nuclear imaging technologies, increased application in various medical fields, and rising healthcare investments across the region. The market is expect...

Europe Nuclear Medicine Market Size, Share, Trends & Analysis by Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters)), by Application (Neurology, Cardiology, Oncology, Others), by End User (Hospitals & Clinics, Diagnostic Centers, Others) and Region, with Forecasts from 2024 to 2034....

Market Overview The Europe Nuclear Medicine Market is expected to witness substantial growth from 2024 to 2034, driven by advancements in nuclear imaging technology, increasing demand for early and accurate diagnosis, and the growing prevalence of chronic diseases such as cancer and car...

North America Nuclear Medicine Market Size, Share, Trends & Analysis by Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters)), by Application (Neurology, Cardiology, Oncology, Others), by End User (Hospitals & Clinics, Diagnostic Centers, Others) and Region, with Forecasts from 2024 to 2034....

Market Overview The North America Nuclear Medicine Market is poised for substantial growth between 2024 and 2034, driven by advancements in diagnostic imaging and therapeutic applications, rising prevalence of chronic diseases, and increasing adoption of nuclear medicine techniques. The...

Global Nuclear Medicine Market Size, Share, Trends & Analysis by Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters)), by Application (Neurology, Cardiology, Oncology, Others), by End User (Hospitals & Clinics, Diagnostic Centers, Others) and Region, with Forecasts from 2024 to 2034....

Market Overview The Global Nuclear Medicine Market is projected to experience significant growth from 2024 to 2034, driven by technological advancements in diagnostic imaging and the increasing demand for targeted radiopharmaceutical therapies. Valued at USD XX.XX billion in 2024, the m...

Asia Pacific Photodynamic Therapy Market Size, Share, Trends & Analysis by Product Type (Photodynamic Therapy Devices, Photosensitizer Drugs), by Application (Active Keratosis, Cancer, Psoriasis, Acne, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others) and Region, with Forecasts from 2024 to 2034....

Market Overview The Asia Pacific Photodynamic Therapy Market is on the brink of significant growth, driven by increasing cancer prevalence, advancements in Photodynamic Therapy technology, and rising awareness about minimally invasive treatment options. Market research indicates a robus...

Europe Photodynamic Therapy Market Size, Share, Trends & Analysis by Product Type (Photodynamic Therapy Devices, Photosensitizer Drugs), by Application (Active Keratosis, Cancer, Psoriasis, Acne, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others) and Region, with Forecasts from 2024 to 2034....

Market Overview The Europe Photodynamic Therapy Market is poised for substantial growth in the coming decade, propelled by increasing cancer incidence, advancements in photodynamic therapy technology, and heightened awareness of minimally invasive treatments. Market research forecasts t...

North America Photodynamic Therapy Market Size, Share, Trends & Analysis by Product Type (Photodynamic Therapy Devices, Photosensitizer Drugs), by Application (Active Keratosis, Cancer, Psoriasis, Acne, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others) and Region, with Forecasts from 2024 to 2034....

Market Overview The North America Photodynamic Therapy Market is projected to witness substantial growth in the coming decade, driven by the rising prevalence of cancer, advancements in Photodynamic Therapy technology, and increasing awareness of minimally invasive treatments. Market re...

Global Photodynamic Therapy Market Size, Share, Trends & Analysis by Product Type (Photodynamic Therapy Devices, Photosensitizer Drugs), by Application (Active Keratosis, Cancer, Psoriasis, Acne, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others) and Region, with Forecasts from 2024 to 2034....

Market Overview The Global Photodynamic Therapy Market is poised to experience substantial growth in the coming decade, driven by the rising prevalence of cancer and other chronic diseases, advancements in PDT technology, and increasing awareness of minimally invasive treatment options....

Cancer-focused Genetic Testing Service Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Cancer-focused Genetic Testing Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsca...

Anti-cancer Drug Exposure Evaluation Services Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Anti-cancer Drug Exposure Evaluation Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive ...